Zeda has announced the acquisition of The Orthopaedic Implant Company (OIC), strengthening its commitment to advancing the distribution of medical devices globally.
Essentium’s public listing fell through when it became clear that the company’s share value would not be above the threshold to receive sufficient PIPE funding six months after its SPAC transaction closed, according to co-founder Blake Teipel.
As we sat down at last year’s Formnext event, Essentium co-founder Blake Teipel explained in detail why the company moved into hardware, why its proposed SPAC deal fell through in 2022, and why the Nexa3D merger makes sense.
TCT Group Content Manager Sam Davies speaks to Velo3D's Interim CEO Brad Kreger about the prospect that the metal additive manufacturing firm could be sold this year.
Carcinotech has raised $5.3 million of funding as the company looks to build on its traction in the UK and Europe, with US expansion planned later this year.
Farhad “Fred” Ebrahimi, and his wife Mary Ebrahimi, have acquired a 5.13% stake in Stratasys, worth approximately 47 million USD. The couple are now a party-at-interest in the company, as detailed in the 13D SEC filing submitted on January 25, 2024.
The cost reduction measures, which also include consolidation of facility footprint and product rationalisation, have been implemented in a bid to ‘accelerate the company's path to profitability.’
The UK-based electron beam 3D printing specialist says the funding will be used to enable the growth of its global customer base and increase its in-house production capacity for its Calibur3 metal AM systems.
The high-power industrial blue laser technology developer received the deficiency letter on December 28, 2023, which determined that shares of its common stock have been selling for a low price per share for a substantial period.
Velo3D has announced that it was notified on December 28, 2023 by the New York Stock Exchange (NYSE) that the company is not in compliance with Rule 802.01C of the NYSE’s Listed Company Manual.
